MPLN MultiPlan
- 0.708
- +0.101+16.62%
MultiPlan News
MultiPlan Wins "Best Overall Healthcare Data Analytics Platform" in 8th Annual MedTech Breakthrough Awards Program
MultiPlan's PlanOptix Platform Recognized for Bringing Price Transparency to the Market MultiPlan Corporation (NYSE:MPLN) ("MultiPlan" or the "Company"), a leading value-added provider of data analytics and
10-Q: Quarterly report
MultiPlan Corp (MPLN) Q1 2024 Earnings: Significant Impairment Charge Leads to Net Loss
MultiPlan (MPLN.US): The 2024 Q1 financial report achieved revenue of US$234.5 million, previous value of US$236.6 million, expected value of US$244.1 million; earnings per share were -0.03 USD, previous value of USD 0.00, and expected value of -0.05 USD.
MultiPlan (MPLN.US): The 2024 Q1 financial report achieved revenue of US$234.5 million, previous value of US$236.6 million, expected value of US$244.1 million; earnings per share were -0.03 USD, previous value of USD 0.00, and expected value of -0.05 USD.
Multiplan GAAP EPS of -$0.83 Misses by $0.77, Revenue of $234.5M Misses by $13.74M
MultiPlan Anticipates Q2 2024 Revenues Of $235M-$250M Versus Consensus Of $252.80M, With Adjusted EBITDA Of $145M-$160M
MultiPlan Anticipates Q2 2024 Revenues Of $235M-$250M Versus Consensus Of $252.80M, With Adjusted EBITDA Of $145M-$160M
Earnings Flash (MPLN) MULTIPLAN CORPORATION Reports Q1 Revenue $234.5M
06:05 AM EDT, 05/08/2024 (MT Newswires) -- Earnings Flash (MPLN) MULTIPLAN CORPORATION Reports Q1 Revenue $234.5M
MultiPlan Sees 2024 Rev $1B-$1.03B >MPLN
MultiPlan Sees 2024 Rev $1B-$1.03B >MPLN
MultiPlan Sees 2024 Adj Ebitda in $630M to $650M Range >MPLN
MultiPlan Sees 2024 Adj Ebitda in $630M to $650M Range >MPLN
MultiPlan Reaffirms 2024 Revenue Guidance Of $1B-$1.03B Versus Consensus Of $1.02B
MultiPlan Reaffirms 2024 Revenue Guidance Of $1B-$1.03B Versus Consensus Of $1.02B
MultiPlan Backs 2024 Guidance>MPLN
MultiPlan Backs 2024 Guidance>MPLN
MultiPlan Q1 2024 GAAP EPS $(0.83), Sales $234.508M Miss $244.121M Estimate
MultiPlan Q1 2024 GAAP EPS $(0.83), Sales $234.508M Miss $244.121M Estimate
MultiPlan 1Q Rev $234.5M >MPLN
MultiPlan 1Q Rev $234.5M >MPLN
Press Release: MultiPlan Reports First Quarter 2024 Results
MultiPlan Reports First Quarter 2024 Results -- Q1 2024 Revenues of $234.5 million, Net Loss of $539.7 million (including a $519.1 million impairment of goodwill and indefinite-lived intangible asset
MultiPlan 1Q Loss/Shr 83c >MPLN
MultiPlan 1Q Loss/Shr 83c >MPLN
MultiPlan Has Identified 1Q Potential Medical Cost Savings of Approximately $5.7B >MPLN
MultiPlan Has Identified 1Q Potential Medical Cost Savings of Approximately $5.7B >MPLN
MultiPlan Reports First Quarter 2024 Results
– Q1 2024 Revenues of $234.5 million, Net Loss of $539.7 million (including a $519.1 million impairment of goodwill and indefinite-lived intangible assets), and Adjusted EBITDA of $146.8 million– Iden
MultiPlan Corporation Announces Participation at Upcoming Conferences
MultiPlan Corporation (NYSE:MPLN) ("MultiPlan" or the "Company"), a leading provider of technology and data-enabled end-to-end cost management, payment and revenue integrity solutions to the U.S. healthcare industry,
Why Clever Leaves Holdings Shares Are Trading Lower By Around 60%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Shares of Clever Leaves Holdings Inc. (NASDAQ:CLVR) fell sharply during Monday's session after the company announced that it will voluntarily delist its common shares from the Nasdaq and deregister it
Tesla, Deciphera Pharmaceuticals, Heartland Financial And Other Big Stocks Moving Higher On Monday
U.S. stocks were higher, with the Nasdaq Composite jumping over 50 points on Monday.Shares of Tesla, Inc. (NASDAQ:TSLA) rose sharply during Monday's session on reports the company will partner with Ba
Analysis
Price Target
No Data
